(Total Views: 521)
Posted On: 06/22/2022 12:02:15 AM
Post# of 157755
Yes thank you, I guess this is what I was trying to say. I was just reading up on does/effect curve. Nice little graph showing that sometimes the drug becomes less effective at higher amounts or plateaus at some point. It’s not always ideal to give more.
“Now somebody just needs to develop the dose/effect curve for some disease entity (NASH or whatever) to see where the sweet spot is. “
“Now somebody just needs to develop the dose/effect curve for some disease entity (NASH or whatever) to see where the sweet spot is. “
(0)
(0)
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
https://firegatebiotech.com/2025
https://zenodo.org/records/17291133?token=eyJ...kN7msthgMA
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
https://firegatebiotech.com/2025
https://zenodo.org/records/17291133?token=eyJ...kN7msthgMA
— Jeremiah 51:36
